Funder: Canadian Institutes of Health Research (CIHR)
Role: Co-Principal Investigators: Saunders N, Toulany A. Co-Investigators: Moran K, Cohen E, Guttman A, Kurdyak P, Moore Hepburn C, Penner M, Stukel T, Sundar P, Vigod S.
Study summary: Neurodevelopmental (e.g., developmental delay) and mental health disorders (e.g., mood, anxiety) frequently emerge and are diagnosed in childhood and adolescence. Early detection and treatment are critical for ensuring optimal health outcomes over the long term. However, the COVID-19 pandemic and its effects, such as widespread closures of in-person activities and limited access to health care have created challenges identifying these disorders promptly. Additionally, the pandemic-related stressors may exacerbate symptoms in children and adolescents with mental health conditions. Our study in Ontario, Canada, aims to provide population level insights into the impact of the pandemic on delays in diagnosis and the changing characteristics of new neurodevelopmental and mental health disorders among children. By filling this crucial knowledge gap, our research will inform service and pandemic recovery planning, helping improve support children and adolescents with these conditions.